Literature DB >> 11912250

Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney.

Frank Eitner1, Tammo Ostendorf1, Claudia Van Roeyen1, Masashi Kitahara1, Xuri Li1, Karin Aase1, Hermann-Josef Gröne1, Ulf Eriksson1, Jürgen Floege1.   

Abstract

Platelet-derived growth factor-C (PDGF-C) is a new member of the PDGF family. Its expression in normal and diseased kidney is unknown. Rabbit antisera were generated against human full-length, core domain, and mouse PDGF-C, and their specificity was confirmed by Western blot analyses. Renal PDGF-C expression was analyzed by immunohistochemistry in normal rats (n = 8), mesangioproliferative anti-Thy 1.1 nephritis (n = 4 each at days 1, 4, 6, and 85), passive Heymann nephritis (PHN, n = 4), puromycin nephrosis (PAN, n = 2), Milan normotensive rats (MN, n = 2), and obese Zucker rats (n = 3). PDGF-C expression was also studied in anti-Thy 1.1 rats treated with PDGF-B aptamer antagonists (n = 5) or irrelevant control aptamers (n = 5). PDGF-C was constitutively expressed in arterial smooth muscle cells and collecting duct epithelial cells. Mesangial PDGF-C was markedly upregulated in anti-Thy 1.1 nephritis in parallel with the peak mesangial cell proliferation. Furthermore, PDGF-CC acted as a potent growth factor for mesangial cells in vitro. Inhibition of PDGF-B via specific aptamers reduced the injury in anti-Thy 1.1 nephritis but did not affect the glomerular PDGF-C overexpression or the mitogenicity of PDGF-CC in vitro. In PHN, PAN, and obese Zucker rats, glomeruli remained negative for PDGF-C despite severe glomerular injury. PDGF-C localized to podocytes at sites of focal and segmental sclerosis in MN. Interstitial PDGF-C expression was increased at sites of fibrosing injury in obese Zucker rats. The use of the different antisera resulted in virtually identical findings. It is concluded that PDGF-C is a novel mesangial cell mitogen that is constitutively expressed in the kidney and specifically upregulated in mesangial, visceral epithelial, and interstitial cells after predominant injury to these cells. PDGF-C may therefore be involved in the pathogenesis of renal scarring.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912250     DOI: 10.1681/ASN.V134910

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  15 in total

1.  Deletion of platelet-derived growth factor receptor-β improves diabetic nephropathy in Ca²⁺/calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic mice.

Authors:  H Suzuki; I Usui; I Kato; T Oya; Y Kanatani; Y Yamazaki; S Fujisaka; S Senda; Y Ishii; M Urakaze; A Mahmood; S Takasawa; H Okamoto; M Kobayashi; K Tobe; M Sasahara
Journal:  Diabetologia       Date:  2011-08-11       Impact factor: 10.122

Review 2.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

3.  PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis.

Authors:  Frank Eitner; Eva Bücher; Claudia van Roeyen; Uta Kunter; Song Rong; Claudia Seikrit; Luigi Villa; Peter Boor; Linda Fredriksson; Gudrun Bäckström; Ulf Eriksson; Arne Ostman; Jürgen Floege; Tammo Ostendorf
Journal:  J Am Soc Nephrol       Date:  2008-01-09       Impact factor: 10.121

4.  Tyrosines-740/751 of PDGFRβ contribute to the activation of Akt/Hif1α/TGFβ nexus to drive high glucose-induced glomerular mesangial cell hypertrophy.

Authors:  Falguni Das; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  Cell Signal       Date:  2017-09-23       Impact factor: 4.315

5.  PDGF-C mediates glomerular capillary repair.

Authors:  Peter Boor; Claudia R C van Roeyen; Uta Kunter; Luigi Villa; Eva Bücher; Bernd Hohenstein; Christian P M Hugo; Ulf Eriksson; Simon C Satchell; Peter W Mathieson; Frank Eitner; Jürgen Floege; Tammo Ostendorf
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 6.  [New approaches in progressive kidney diseases].

Authors:  P Boor
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 7.  Renal fibrosis: novel insights into mechanisms and therapeutic targets.

Authors:  Peter Boor; Tammo Ostendorf; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2010-09-14       Impact factor: 28.314

Review 8.  The PDGF family in renal fibrosis.

Authors:  Tammo Ostendorf; Frank Eitner; Jürgen Floege
Journal:  Pediatr Nephrol       Date:  2011-05-21       Impact factor: 3.714

9.  VEGF-independent angiogenic pathways induced by PDGF-C.

Authors:  Xuri Li; Anil Kumar; Fan Zhang; Chunsik Lee; Yang Li; Zhongshu Tang; Pachiappan Arjuna
Journal:  Oncotarget       Date:  2010-08

10.  Anti-apoptotic and Matrix Remodeling Actions of a Small Molecule Agonist of the Human Relaxin Receptor, ML290 in Mice With Unilateral Ureteral Obstruction.

Authors:  Hooi Hooi Ng; Mariluz Soula; Bryan Rivas; Kenneth J Wilson; Juan J Marugan; Alexander I Agoulnik
Journal:  Front Physiol       Date:  2021-07-07       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.